Virginia G Kaklamani Selected Research

B7-H1 Antigen

1/2021

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginia G Kaklamani Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2003
20	Neoplasms (Cancer) 08/2023 - 04/2003
5	Triple Negative Breast Neoplasms 11/2023 - 06/2015
3	Obesity 07/2017 - 10/2008
3	Colorectal Neoplasms (Colorectal Cancer) 01/2011 - 09/2003
2	Pathologic Complete Response 11/2023 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 09/2003
1	Genomic Instability 11/2023
1	Circulating Neoplastic Cells 08/2023
1	Nausea 10/2022
1	Chromothripsis 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 07/2018
1	Weight Gain 07/2017
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2014
1	Ductal Carcinoma 05/2014
1	Carcinogenesis 01/2012
1	Hyperinsulinism (Hyperinsulinemia) 10/2008
1	Disease Progression 01/2007
1	Brain Neoplasms (Brain Tumor) 04/2006
1	Diarrhea 03/2005
1	Hematologic Neoplasms (Hematological Malignancy) 09/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 08/2023 - 01/2005
10	Estrogen ReceptorsIBA 11/2023 - 08/2012
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 04/2012
5	AdiponectinIBA 06/2013 - 05/2008
4	human ERBB2 proteinIBA 10/2022 - 08/2012
4	Tamoxifen FDA LinkGeneric 07/2021 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2008
4	Transforming Growth Factor-beta Type I ReceptorIBA 12/2008 - 09/2003
3	elacestrantIBA 08/2023 - 10/2019
3	eribulin FDA Link 01/2021 - 06/2015
3	AnthracyclinesIBA 01/2020 - 04/2003
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2005
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2008 - 08/2004
2	Fulvestrant (Faslodex)FDA Link 08/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2015
2	Lapatinib (GW572016)FDA Link 01/2019 - 04/2012
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 04/2012
2	LigandsIBA 01/2018 - 08/2004
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2017
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2017
2	Capecitabine (Xeloda)FDA Link 05/2011 - 04/2003
2	Adiponectin ReceptorsIBA 10/2008 - 05/2008
2	Taxoids (Taxanes)IBA 01/2005 - 01/2003
1	PlatinumIBA 11/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 10/2022
1	Medical MarijuanaIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 10/2021
1	sapanisertibIBA 07/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2021
1	B7-H1 AntigenIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	taxaneIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	RAD1901IBA 10/2019
1	Aromatase InhibitorsIBA 10/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	pertuzumabIBA 01/2019
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	ParaffinIBA 11/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 06/2015
1	Yttrium-90IBA 10/2014
1	Metformin (Glucophage)FDA LinkGeneric 08/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2012
1	Phosphotransferases (Kinase)IBA 04/2012
1	Insulin (Novolin)FDA Link 01/2012
1	LeptinIBA 01/2012
1	ixabepilone (BMS 247550)FDA Link 05/2011
1	Messenger RNA (mRNA)IBA 05/2008
1	Cytotoxins (Cytolysins)IBA 01/2007
1	efaproxiral (RSR-13)IBA 04/2006
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2005
1	Monoclonal AntibodiesIBA 01/2005
1	ErbB-2 ReceptorIBA 01/2005
1	Fluorouracil (Carac)FDA LinkGeneric 04/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2003
1	Antineoplastic Agents (Antineoplastics)IBA 04/2003
1	Epirubicin (Ellence)FDA LinkGeneric 04/2003

Therapy/Procedure

21	Therapeutics 11/2023 - 04/2003
9	Drug Therapy (Chemotherapy) 10/2022 - 03/2005
5	Adjuvant Chemotherapy 01/2020 - 01/2003
3	Neoadjuvant Therapy 07/2021 - 06/2015
3	Radiotherapy 01/2012 - 03/2005
2	Aftercare (After-Treatment) 01/2022 - 07/2017
1	Immunotherapy 01/2021
1	Biological Therapy 01/2007
1	Duration of Therapy 01/2007
1	Chemoprevention 08/2004